Media

-ITI Board adds significant oncology drug development and commercialization expertise to the Board- May 05, 2020 08:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”) a privately-held clinical-stage

-Proceeds to support acceleration of Phase II clinical trial for GBM, advancement of pipeline, including development of COVID-19 vaccine candidate and expansion of opportunities for its UNITE nucleic acid platform-

GOLDEN, Colo., April 14, 2020 /PRNewswire/ -- PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Tropis® Needle-free injection system will be used to deliver a COVID-19 vaccine being

April 09, 2020 04:00 PM Eastern Daylight Time   ROCKVILLE, Md. & PROVIDENCE, R.I. & GOLDEN, Colo.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., a privately held clinical stage biotechnology company pioneering the study

Poster Title: Lysosomal-associated membrane protein-1-targeting of Epstein–Barr virus nuclear antigen 1 (EBNA1) elicits potent immune responses and inhibits tumor growth in preclinical studies by Dr. Pratima Sinha, Ph.D. Presentation Date:

Accelerate the Discovery, Translation & Clinical Development of Safe, Effective & Deliverable Therapies to Patients in Need Last December, 60+ thought-leaders including neuro-oncologists, neurosurgeons and oncology professionals from biopharma will

Society for NeuroOncology Annual Meeting   Advancing multi-disciplinary brain tumor research, education, and collaboration to drive discovery and improve patient care https://soc-neuro-onc.org/SNO/News/2020_SNO_Annual_Meeting.aspx

The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on

About the Immuno-Oncology Summit Over the past 8 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across

When collaboration is more vital than ever, you can still rely on BIO to bring the industry together. For 2020, the BIO International Convention will transition to a new, virtual

Onco Cell Therapy Summit is dedicated to translating your novel data assets & IP into commercially viable oncological therapies. OCTS is a 4-track event and whilst bringing together the key

- Meeting on ITI-1001 Phase I program for treatment of Newly-Diagnosed Glioblastoma (GBM) - March 03, 2020 08:00 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., a privately held